Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 43, Issue 7, Pages 802-813
Publisher
Wiley
Online
2016-02-04
DOI
10.1111/apt.13548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects
- (2015) Grace Lai-Hung Wong et al. HEPATOLOGY
- Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
- (2015) Dong Hyun Sinn et al. HEPATOLOGY
- Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study
- (2014) C. C. N. Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis B virus infection
- (2014) Christian Trépo et al. LANCET
- Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis
- (2013) Grace Lai-Hung Wong et al. HEPATOLOGY
- A tutorial on propensity score estimation for multiple treatments using generalized boosted models
- (2013) Daniel F. McCaffrey et al. STATISTICS IN MEDICINE
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
- (2012) Chun-Ying Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Who will have the best response to entecavir?
- (2012) Grace Lai-Hung Wong JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
- (2011) J. S.-W. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Landmark Analysis at the 25-Year Landmark Point
- (2011) Urania Dafni
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
- (2011) Henry Lik-Yuen Chan et al. JOURNAL OF HEPATOLOGY
- Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?
- (2011) Charing Ching-Ning Chong et al. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
- Meta-analysis: reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B
- (2010) G. L.-H. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- (2010) Masao Omata et al. Hepatology International
- Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
- (2009) Jaw-Ching Wu et al. JOURNAL OF HEPATOLOGY
- Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
- (2008) Juan R Larrubia et al. WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started